Published in Blood on February 15, 2000
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification. J Exp Med (2002) 1.45
Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells. Blood (2007) 1.01
Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment. Biochim Biophys Acta (2015) 0.98
HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses. J Clin Invest (2005) 0.95
Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule. Am J Pathol (2007) 0.93
Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component. Am J Surg Pathol (2011) 0.87
Role of surface IgM and IgD on survival of the cells from B-cell chronic lymphocytic leukemia. Blood (2002) 0.85
Differentiation of chronic lymphocytic leukemia B cells into immunoglobulin secreting cells decreases LEF-1 expression. PLoS One (2011) 0.80
Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia. J Immunol (2016) 0.80
FcγRIIb expression in early stage chronic lymphocytic leukemia. Leuk Lymphoma (2017) 0.75
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood (1999) 11.57
Expression of a receptor for IgM by human T cells in vitro. Eur J Immunol (1975) 5.05
Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. J Immunol (1976) 4.64
High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet (1981) 4.39
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest (1998) 3.96
Receptors for IgG molecules on human lymphocytes forming spontaneous rosettes with sheep red cells. Eur J Immunol (1975) 3.26
Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents. J Immunol (2000) 3.13
A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med (1999) 2.86
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med (1996) 2.51
The release of platelet-activating factor from human endothelial cells in culture. J Immunol (1983) 2.41
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients. Ann Oncol (2008) 2.28
Cryptic deletions are a common finding in "balanced" reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet (2007) 2.21
Identification and mapping of human cDNAs homologous to Drosophila mutant genes through EST database searching. Nat Genet (1996) 2.13
Progressive Muscular Dystrophy. V. The Identification of the Carrier State in the Duchenne Type by Serum Creatine Kinase Determination. Am J Hum Genet (1963) 2.12
EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients. Ann Oncol (2007) 2.11
Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet (2008) 2.09
Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand (1978) 1.98
The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med (1999) 1.97
Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet (1985) 1.88
Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast. J Pathol (2001) 1.78
Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood (1999) 1.71
Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nat Med (2001) 1.66
Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol (2000) 1.64
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Screening of JAK2 V617F mutation in multiple myeloma. Leukemia (2006) 1.59
Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol (1998) 1.59
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population. Br J Haematol (2001) 1.57
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. Ann Oncol (2012) 1.57
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients. Br J Cancer (2008) 1.55
Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species. J Med Microbiol (1988) 1.54
The same molecular mechanism at the maternal meiosis I produces mono- and dicentric 8p duplications. Am J Hum Genet (1996) 1.53
Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis. J Immunol (1985) 1.52
The demonstration of acid alpha-naphthyl acetate esterase activity in human lymphocytes: usefulness as a T-cell marker. Cell Immunol (1978) 1.52
A single protein immunologically identified as CD38 displays NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes. Biochem Biophys Res Commun (1993) 1.52
Two novel Italian CADASIL families from Central Italy with mutation CGC-TGC at codon 1006 in the exon 19 Notch3 gene. Neurol Sci (2006) 1.51
The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation. Blood (1989) 1.51
Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As(2)O(3)) on myeloma cells. Leuk Res (2001) 1.46
Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations. J Med Genet (2001) 1.46
Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. J Immunol (1994) 1.44
Screening for primary aldosteronism with a logistic multivariate discriminant analysis. Clin Endocrinol (Oxf) (1998) 1.43
Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis. Results of a preliminary study. Clin Exp Rheumatol (1993) 1.43
dsDNA-, nucleohistone- and DNASE I-reactive T lymphocytes in patients affected by systemic lupus erythematosus: correlation with clinical disease activity. Clin Exp Rheumatol (1997) 1.43
Characterization of human T-cell subpopulations as defined by specific receptors for immunoglobulins. Contemp Top Immunobiol (1978) 1.42
Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum Mol Genet (1996) 1.42
Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative. J Antibiot (Tokyo) (1981) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Human CD38: a (r)evolutionary story of enzymes and receptors. Leuk Res (2001) 1.41
Functional characterization of an antigen involved in an early step of T-cell activation. Proc Natl Acad Sci U S A (1987) 1.41
Patient compliance with homeopathic therapy. Homeopathy (2006) 1.41
CV 205-502 treatment in therapy-resistant acromegalic patients. Eur J Endocrinol (1995) 1.40
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis (2012) 1.40
[Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus]. Minerva Med (1992) 1.39
Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases. Am J Hematol (1996) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
FORTRAN interface for code interoperability in quantum chemistry: the Q5Cost library. J Chem Inf Model (2007) 1.39
Ultrastructure and cytochemistry of human peripheral blood lymphocytes. Similarities between the cells of the third population and TG lymphocytes. Eur J Immunol (1980) 1.38
Auditory hallucinations suppressed by etizolam in a patient with schizophrenia. Can J Psychiatry (1993) 1.38
Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod (2000) 1.38
Receptors for IgM on certain human B lymphocytes. J Immunol (1977) 1.37
Terrestrial gamma-ray flashes as powerful particle accelerators. Phys Rev Lett (2011) 1.35
CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood (1996) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins (1980) 1.33
Studies with ubiquinone-depleted submitochondrial particles. Effects of extraction and reincorporation of ubiquinone on the kinetics of succinate dehydrogenase. Eur J Biochem (1970) 1.33
Deletion of a 5-cM region at chromosome 8p23 is associated with a spectrum of congenital heart defects. Circulation (2000) 1.32
Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS (2000) 1.30
Human T cell receptor for IgM: specificity for the pentameric Fc fragment. Eur J Immunol (1976) 1.30
Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J Clin Invest (1985) 1.30
Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome. J Infect Dis (1985) 1.29
Human CD38, a cell-surface protein with multiple functions. FASEB J (1996) 1.29
Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol (1990) 1.28
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost (2007) 1.28
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood (2001) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Human lymphocytes bearing "Ia-like" antigens; absence in patients with infantile agammaglobulinemia. J Immunol (1977) 1.26
DiGeorge anomaly associated with 10p deletion. Am J Med Genet (1991) 1.25
Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer. Br J Cancer (2012) 1.24
Intensive utilisation of a dialysis unit. Proc Eur Dial Transplant Assoc (1973) 1.23
The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost (2005) 1.22
Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J Cereb Blood Flow Metab (2003) 1.22
In vitro selective expansion of allergen specific T cells from atopic patients. Clin Exp Immunol (1983) 1.21
CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. J Immunol (1991) 1.20
Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions. J Med Microbiol (1986) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Intestinal side-effects of docetaxel/vinorelbine combination. Lancet (2000) 1.19
Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol (1992) 1.19
Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity. AIDS (2001) 1.19
Airway obstructions associated with congenital heart disease in infancy. J Thorac Cardiovasc Surg (1990) 1.18
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med (1995) 1.17
Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. Neurology (2007) 1.16
Interaction between rifampicin and trimethoprim in vitro and in experimental infections. J Antimicrob Chemother (1977) 1.16
Intracellular levels of the LIS1 protein correlate with clinical and neuroradiological findings in patients with classical lissencephaly. Ann Neurol (1999) 1.16
Large granular lymphocytes in human peripheral blood: ultrastructural and cytochemical characterization of the granules. Blood (1982) 1.16
The direct economic cost of pharmacologically-treated diabetes in Italy-2006. The ARNO observatory. Nutr Metab Cardiovasc Dis (2010) 1.15
Replicon clusters may form structurally stable complexes of chromatin and chromosomes. J Cell Sci (1994) 1.13